Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Quanterix Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
17.6
22.9
37.6
56.7
86.4
111
106
122
137
139
Cost of revenue
9.84
12.9
19.7
29.9
38.2
45.8
60.2
48.1
54.3
73.9
Gross profit
7.75
9.99
17.9
26.8
48.2
64.8
45.4
74.2
83.1
65
Research and development
17
16.3
15.8
16.2
20.2
28.4
26.8
26.1
31.1
35.9
Selling, general and administrative
12.5
19.7
33.7
52.2
59.6
92.9
91.9
89.1
102
138
Operating expenses
29.5
36
49.5
68.4
79.8
121
150
120
136
191
Operating income
-21.7
-26
-31.6
-41.6
-31.6
-56.5
-104
-46
-52.6
-126
Other non-operating income
-0.16
-0.06
-0.01
-0.01
-0.05
1.34
-0.28
2.52
-0.14
0.16
Pre-tax income
-23.2
-27
-31.5
-41
-31.9
-55.6
-99.4
-27.6
-38.1
-112
Income tax
0
0.03
-0.19
-0.38
-0.04
0.16
0.72
0.43
-5.12
Net income
-23.2
-27
-31.5
-40.8
-31.5
-55.5
-99.6
-28.4
-38.5
-107
EBITDA
-21.3
-25.5
-30.2
-38.6
-27.3
-51.6
-98.9
-39.7
-46.2
-110
EPS, basic
-1.63
-1.07
-1.54
-2.69
-0.75
-1.00
-2.51
EPS, diluted
-1.63
-1.07
-1.54
-2.69
-0.75
-1.00
-2.51
Shares, basic (weighted)
2.14
3.76
22
25.1
29.6
36
37
37.6
38.4
42.6
Shares, diluted (weighted)
2.14
3.76
22
25.1
29.6
36
37
37.6
38.4
42.6
Balance sheet
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
29.7
79.7
44.4
109
182
396
339
174
56.7
29.8
Short-term investments
0
6.89
0
88.4
Receivables
5.6
6.79
10.9
17.2
23.8
19
25.4
32.1
30
Inventory
3.57
5.95
10.5
14.9
22.2
17
26.1
32.8
54.8
Other current assets
0.4
2.33
2.14
5.98
6.51
6.8
9.23
9.56
9.29
Total current assets
89.3
59.5
133
220
449
382
382
364
212
Property, plant and equipment
1.87
2.92
12
13.9
18
19.8
17.9
17.2
23.7
Lease right-of-use assets
12
11.5
21.2
18.3
16.3
16.7
Goodwill
1.31
9.35
10.5
9.63
0
0
0
26.4
Intangible assets
2.35
14.3
13.7
10.5
7.52
6.03
4.03
132
Other non-current assets
0.65
0.54
0.56
0.36
0.38
0.91
1.66
2.81
4.67
Total assets
91.8
67.6
170
271
502
434
429
407
419
Accounts payable
3.55
5.11
5.78
6.8
9.21
3.84
5.05
6.95
13.6
Deferred revenue
4.94
5.44
4.7
5.42
6.36
8.64
9.47
8.83
20.7
Short-term debt
5.04
0.08
7.67
Total current liabilities
19.7
18.1
19.8
39.8
37
31.3
39
42
74.8
Long-term debt
4.35
7.62
7.59
Lease liabilities
21.9
20.5
41.4
37.2
32.6
29.3
Other non-current liabilities
0.14
0.28
13.4
2.65
2.04
1.47
1.18
0.8
8.1
Total liabilities
25.9
26.5
41.3
64.9
60.6
75.7
78.6
76.5
123
Total debt
9.38
7.76
7.69
7.69
Paid-in capital
210
217
345
451
746
764
783
803
874
Retained earnings
-144
-176
-216
-248
-305
-403
-432
-470
-577
Other comprehensive income
-0.15
2.43
0.44
-2.54
-1.67
-3.08
-0.72
Shareholders' equity
-115
65.9
41.1
129
206
443
358
350
330
296
Total equity
-115
65.9
41.1
129
206
443
358
350
330
296
Total liabilities and equity
91.8
67.6
170
271
502
434
429
407
419
Shares outstanding
21.7
22.4
28.1
31.8
36.8
37.3
38
38.6
46.7
Cash flow statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-23.2
-27
-31.5
-40.8
-31.5
-55.5
-99.6
-28.4
-38.5
-107
Depreciation and amortization
0.44
0.48
1.35
3.01
4.31
4.88
5.41
6.28
6.46
15.8
Stock-based compensation
0.93
2.17
4.88
6.39
10.1
16
15.4
16.8
20
20.7
Deferred income tax
0.01
-0.3
-0.49
-0.41
-0.3
-0.29
-0.29
-5.63
Change in receivables
-1.66
-1.68
-0.98
-3.53
-6.73
-6.85
5.16
-6.7
-7.7
10.6
Change in inventory
-0.53
-2.04
-1.6
-3.45
-5.12
-10.1
7.24
-8.94
-6.68
4.03
Cash from operations
-17.7
-22.1
-28.7
-26.2
-23.4
-47.6
-48.6
-18.8
-35.2
-77.2
Capital expenditures
-0.53
-1.13
-1.52
-10.8
-3.93
-13.7
-11.6
-3.84
-3.37
-2.61
Acquisitions
-0.3
-3.8
-14.5
0
0
-93.2
Purchases of investments
-0.15
0
0
-176
-296
-69.8
Sales and maturities of investments
0
0
0
0
35.9
Cash from investing
-0.83
-1.13
-5.45
-25.4
-0.63
-6.4
-11.1
-148
-82.3
50.2
Stock issued
45.4
8.42
-0.02
2.82
4.02
7.75
1.43
Cash from financing
45.9
73.2
-0.08
116
96.2
271
2.31
2.69
0.46
-0.71
Exchange rate effect
0.12
0.16
-0.09
-0.54
0.3
-0.73
1.57
Net change in cash
27.3
50
-34.3
64.6
72.2
217
-57.2
-165
-117
-27.7
Free cash flow
-18.3
-23.2
-30.2
-37
-27.3
-61.3
-60.2
-22.7
-38.5
-79.8
Interest paid
0.95
0.74
0.61
0.66
0.63
0.39
0
0
Income taxes paid
0
0.68
0.8
0.9
1.4
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.27 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
44.6%
Gross profit / revenue.
Operating margin
-99.6%
Operating income / revenue.
EBITDA margin
-84.4%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-81.7%
Pre-tax income / revenue.
Net margin
-80.2%
Net income / revenue.
FCF margin
-53.2%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-52.7%
Cash from operations / revenue.
Return on equity (ROE)
-51.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-38.5%
Net income / average total assets.
Return on invested capital (ROIC)
-62.6%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
20.8%
Research and development expense / revenue.
SG&A / revenue
85.6%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
12.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.5%
Capital expenditures / revenue.
D&A / revenue
15.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
1.1%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
9.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
10.0%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-21.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
12.7%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
6.2%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-10.4%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-6.2%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
7.5%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
3.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-1.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
9.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
11.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
7.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.40x
Current assets / current liabilities.
Quick ratio
2.30x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.86x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$2.61
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$3.25
Revenue / diluted weighted shares.
FCF per share
-$1.73
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$1.72
Cash from operations / diluted weighted shares.
Book value per share
$5.03
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.01x
Market cap / revenue.
P/B
0.65x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.18x
Market cap / tangible book value, when positive.
EV/Sales
0.40x
Enterprise value / revenue.
FCF yield
-52.8%
Free cash flow / market cap.
Earnings yield
-79.6%
Net income / market cap (the inverse of P/E).
What was Quanterix Corp's revenue in fiscal 2025?
Quanterix Corp reported revenue of $138.9M for fiscal 2025, 1.1% higher than the year before.
Was Quanterix Corp profitable in fiscal 2025?
No. It reported a net loss of $107.2M.
How much free cash flow did Quanterix Corp generate in fiscal 2025?
Cash from operations of $77.2M minus capital expenditures of $2.6M left free cash flow of -$79.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.